Manufacturer of Controlled Substances; Notice of Registration, 65750 [2011-27424]
Download as PDF
<![CDATA[
65750
Federal Register / Vol. 76, No. 205 / Monday, October 24, 2011 / Notices
the basic classes of controlled
substances listed.
Dated: October 3, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–27430 Filed 10–21–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 7, 2011, and
published in the Federal Register on
June 16, 2011, 76 FR 35243, American
Radiolabeled Chemicals, Inc., 101 Arc
Drive, St. Louis, Missouri 63146, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
tkelley on DSK3SPTVN1PROD with NOTICES
Dated: October 3, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
(Pub. L. 94–409) (5 U.S.C. 552b)
[FR Doc. 2011–27424 Filed 10–21–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
I
Advisory Board Meeting
Time and Date: 8 a.m. to 4:30 p.m. on
Wednesday, November 2, 2011, 8 a.m.
to 4:30 p.m. on Thursday, November 3,
2011.
Place: Stanford University Law
School, 550 Nathan Abbott Way,
Stanford, California, (650) 724–6258.
Matters To Be Considered:
Organizational culture and change in
the correctional environment;
Performance Based Outcomes; Director’s
report; Presentations.
Contact Person for More Information:
Thomas Beauclair, Deputy Director,
202–307–3106, ext. 44254.
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Morris L. Thigpen,
Director.
[FR Doc. 2011–27157 Filed 10–21–11; 8:45 am]
BILLING CODE 4410–36–M
II
II
II
II
II
II
Jkt 226001
DEPARTMENT OF JUSTICE
United States Parole Commission
Sunshine Act Meeting; Record of Vote
of Meeting Closure
I, Isaac Fulwood, of the United States
Parole Commission, was present at a
meeting of said Commission, which
started at approximately 11 a.m., on
Thursday, September 8, 2011, at the
U.S. Parole Commission, 90 K Street,
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
In witness whereof, I make this official
record of the vote taken to close this
meeting and authorize this record to be
made available to the public.
Dated: September 15, 2011.
Isaac Fulwood,
Chairman, U.S. Parole Commission.
[FR Doc. 2011–27571 Filed 10–20–11; 4:15 pm]
National Institute of Corrections
I
I
I
I
I
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
15:34 Oct 21, 2011
NE., Third Floor, Washington, DC
20530. The purpose of the meeting was
to discuss four original jurisdiction
cases pursuant to 28 CFR 2.27. Four
Commissioners were present,
constituting a quorum when the vote to
close the meeting was submitted.
Public announcement further
describing the subject matter of the
meeting and certifications of the General
Counsel that this meeting may be closed
by votes of the Commissioners present
were submitted to the Commissioners
prior to the conduct of any other
business. Upon motion duly made,
seconded, and carried, the following
Commissioners voted that the meeting
be closed: Isaac Fulwood, Cranston J.
Mitchell, Patricia Cushwa and J. Patricia
Wilson Smoot.
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Dimethyltryptamine (7435) ...........
1-[1-(2-Thienyl) cyclohexyl] piperidine (7470).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Heroin (9200) ...............................
Meperidine (9230) ........................
Metazocine (9240) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Phenazocine (9715) .....................
Fentanyl (9801) ............................
VerDate Mar<15>2010
American Radiolabeled Chemicals, Inc.
to manufacture the listed basic classes
of controlled substances is consistent
with the public interest at this time.
DEA has investigated American
Radiolabeled Chemicals Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
BILLING CODE 4410–01–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (11–105)]
Aerospace Safety Advisory Panel;
Charter Renewal
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of renewal and
amendment of the charter of the NASA
Aerospace Safety Advisory Panel.
AGENCY:
Pursuant to sections 14(b)(1)
and 9(c) of the Federal Advisory
Committee Act (Pub. L. 92–463), and
after consultation with the Committee
Management Secretariat, General
Services Administration, the NASA
Administrator has determined that a
renewal and amendment of the charter
of the NASA Aerospace Safety Advisory
Panel is in the public interest in
connection with the performance of
duties imposed on NASA by law. The
renewed charter is for a two-year period
ending October 13, 2013. It is identical
to the previous charter in all respects
except it removes references to areas of
responsibility that are no longer
applicable, updates legal citations, and
conforms the text to the most recent
Congressional reauthorization for this
Federal advisory committee (Pub. L.
111–314 on December 18, 2010).
SUMMARY:
E:\FR\FM\24OCN1.SGM
24OCN1
]]>Agencies
[Federal Register Volume 76, Number 205 (Monday, October 24, 2011)]
[Notices]
[Page 65750]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27424]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 7, 2011, and published in the Federal Register
on June 16, 2011, 76 FR 35243, American Radiolabeled Chemicals, Inc.,
101 Arc Drive, St. Louis, Missouri 63146, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Dimethyltryptamine (7435).................. I
1-[1-(2-Thienyl) cyclohexyl] piperidine I
(7470).
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Heroin (9200).............................. II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Phenazocine (9715)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances as radiolabeled compounds for biochemical
research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
American Radiolabeled Chemicals, Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated American Radiolabeled Chemicals Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: October 3, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-27424 Filed 10-21-11; 8:45 am]
BILLING CODE 4410-09-P
